Jack Levine - 05 Nov 2021 Form 4/A - Amendment Insider Report for EzFill Holdings Inc (NXXT)

Role
Director
Signature
/s/ Jack Levine
Issuer symbol
NXXT
Transactions as of
05 Nov 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
16 Nov 2021, 16:46:06 UTC
Date Of Original Report
09 Nov 2021
Previous filing
14 Sep 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EZFL Common Stock Award $0 +20,477 +154% $0.000000 33,763 05 Nov 2021 Direct F1
holding EZFL Common Stock 186,010 05 Nov 2021 Cameo Life Sciences Investments LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On 11/05/2021, Mr. Levine was awarded $60,000 worth of restricted common stock pursuant to the EzFill 2020 Incentive Compensation Plan, with the common stock valued at the closing price on November 4, 2021 ($2.93 per share). These restricted shares of common stock will vest at the Company's next annual shareholders' meeting only if Mr. Levine remains a member of the Company's board of directors until such meeting.
F2 Jack Levine is the Manager of Cameo Life Sciences Investments LLC and beneficially owns 186,010 shares of common stock, which are held by Cameo Life Sciences Investments, LLC.

Remarks:

This amendment is being filed to revise Item 4 of Table 1 to note that the price should be $0 as the shares were granted in connection with the Reporting Person's service as a member of the Company's board of directors.